Status:
UNKNOWN
The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) Patients
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Smoking
COPD
Eligibility:
All Genders
Brief Summary
Smoking is the most important risk factor of COPD, but only a fourth of smokers had COPD in their life. There are also healthy smokers without evidence of COPD. Investigators hypothesize that innate i...
Eligibility Criteria
Inclusion
- All patients who will have lung resection for the therapeutic cause.
Exclusion
- Patients who do not agree with our study protocol
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01226199
Start Date
October 1 2010
End Date
March 1 2012
Last Update
June 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam, Gyeongi, South Korea, 482 060